Oncology/Hematology

Leukemia

More in Leukemia

Adding Mylotarg to Chemo Fails to Boost Survival in NPM1-Mutated AML

But trial detects "meaningful benefit" when it comes to relapse, editorialists say

May 15, 2023
 A photo of the vial and packaging of Mylotarg.
Childhood Cancer Survivors Have Increased Rates of Late, Major Surgeries

Magnitude of the risk is "striking," editorialists say

May 14, 2023
A photo of a little boy, bald from chemotherapy playing in an outdoor playground.
FLT3 Inhibitor Doubles Overall Survival in Acute Myeloid Leukemia

Median OS improved from 15 months to nearly 32 months with quizartinib

May 09, 2023
A photo of a mature man receiving chemotherapy.
Blinatumomab Plus Chemo Effective in Aggressive Infant ALL

Low incidence of relapse after treatment "remarkable," researchers say

Apr 26, 2023
A photo of vials of Blincyto over a computer rendering of the destruction of lymphoblast cells
Blood, Breast Cancer Survivors Stand Out for Heart Risks Over a Decade Later

Research suggests cancer-specific precision monitoring and risk stratification

Apr 19, 2023
A photo of a mature woman holding a pink breast cancer ribbon.
FDA OKs Cell Therapy to Lower Infection Risk After Stem Cell Transplant

Omidubicel reduced infections in blood cancer patients from 60% to 39% at 100 days posttransplant

Apr 17, 2023
FDA APPROVED omidubicel (Omisirge) over a computer rendering of leukemia cells in the blood stream.
Shortage of Prostate Cancer Drug; Win for DBT Mammo; Double Lung Transplant

News, features, and commentary about cancer-related issues

Mar 16, 2023
Onco Break over a computer rendering of a cancer cell.
Maternal Infection May Play Role in Child's Leukemia

Genitourinary tract infections in particular associated with greater risk

Feb 20, 2023
 A computer rendering of a bladder releasing bacteria.
Cancer and Heart Disease; Screening During COVID; CBD for Smoking Cessation

News, features, and commentary about cancer-related issues

Feb 17, 2023
Onco Break over a computer rendering of a cancer cell.
Targeted Agents Go Head-to-Head for Newly Diagnosed Ph+ ALL

Trial crowns a winner, but how relevant is it amid the changing therapeutic landscape for ALL?

Feb 16, 2023
A photo of a bottle of Iclusig (ponatinib) tablets over a computer rendering of an acute myelogenous leukemia cell
The 'Extreme' Story of How Two Game-Changing Cancer Drugs Came to Market

New book by former Forbes senior editor pulls back the curtain on drug development

Feb 13, 2023
A photo of Nathan Vardi and the cover of his book, For Blood and Money
Survival Outcomes in Young ALL Vary by Race/Ethnicity

White and Asian patients have better survival rates than Black and Hispanic patients

Feb 01, 2023
A close up of an intravenous line attached to child’s brown hand.
ODAC to Review Lymphoma Drug; Tobacco Control; Artificial Skin Aids Cancer Studies

News, features, and commentary about cancer-related issues

Jan 27, 2023
Onco Break over a computer rendering of a cancer cell.
FDA Greenlights BTK Inhibitor Zanubrutinib for CLL/SLL

Phase III studies showed the drug's efficacy, safety in first-line, relapsed/refractory settings

Jan 20, 2023
FDA APPROVED zanubrutinib (Brukinsa) over a microscope of chronic lymphocytic leukemia
More in Leukemia

Continuing Medical Education